Atai Life Sciences N.V. (NASDAQ:ATAI) price on Friday, October 08, fall -4.71% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $12.55.
A look at the stock’s price movement, the close in the last trading session was $13.17, moving within a range at $12.3501 and $13.35. Turning to its 52-week performance, $22.91 and $12.85 were the 52-week high and 52-week low respectively. Overall, ATAI moved -26.05% over the past month.
Analysts project the company’s earnings per share (EPS) to be -$0.21, which has seen fiscal year 2021 EPS growth forecast to increase to -$0.82 and about -$0.97 for fiscal year 2022.
Revisions could be used as tool to get short term price movement insight, and for the company that in the past seven days was no upward and no downward review(s).
11 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 1 analyst(s) rate the stock as a Hold, 10 recommend ATAI as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
ATAI’s current price about -17.01% and -18.72% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 28.78, while 7-day volatility ratio is 5.82% and 5.21% in the 30-day chart. Further, Atai Life Sciences N.V. (ATAI) has a beta value of 0, and an average true range (ATR) of 0.79. Analysts have given the company’s stock an average 52-week price target of $29.10, forecast between a low of $19.00 and high of $45.00. Looking at the price targets, the low is -51.39% off current price level while to achieve the yearly target high, price needs to move -258.57%. Nonetheless, investors will most likely welcome a -115.14% jump to $27.00 which is the analysts’ median price.
In the market, a comparison of Atai Life Sciences N.V. (ATAI) and its peers suggest the former has performed considerably weaker. Elsewhere, the overall performance for the S&P 500 and Dow Jones Industrial shows that the indexes are down -0.19% and -0.03% respectively in the last trading.
If we refocus on Atai Life Sciences N.V. (NASDAQ:ATAI), historical trading data shows that trading volumes averaged 327.17K over the past 3 months.
The 9.67% of Atai Life Sciences N.V.’s shares are in the hands of company insiders while institutional holders own 19.00% of the company’s shares. Current price change has pushed the stock -35.48% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the ATAI stock continues to rise going into the next quarter.